Archives for May 19, 2014

← 2014

EU ombudsman takes issue with trial transparency moves by EMA

By Zachary Brennan

In a letter to the EMA (European Medicines Agency), the European Ombudsman Emily O'Reilly has expressed concern that a significant change of policy on trial data transparency could limit the amount of data that becomes available.